DOI . ORG {}

Detected CMS Systems:

Typesetter CMS (3 occurrences)

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Schema
Social Networks
External Links
Libraries
Hosting Providers
CDN Services

We began analyzing https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.583572/full, but it redirected us to https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.583572/full. The analysis below is for the second page.

Title[redir]:
Frontiers | Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-Cadherin
Description:
Anthracyclines resistance is commonly seen in patients with estrogen receptor α (ERα) positive breast cancer. Epithelial-mesenchymal transition (EMT), which ...

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Doi.org uses TYPESETTER CMS.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month

Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don't see any clear sign of profit-making.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

cells, cancer, dox, breast, ecadherin, expression, erα, mdamb, cell, snail, twist, full, doi, abstract, text, google, scholar, treatment, pubmed, crossref, erαpositive, figure, doxorubicin, mcf, emt, erαnegative, transition, resistance, transcription, tumor, sensitivity, china, patients, epithelialmesenchymal, university, mesenchymal, chemoresistance, treated, estrogen, mcfadr, upregulated, zhang, epithelial, factors, control, detected, receptor, mouse, data, incubated,

Topics {✒️}

stat3/oct-4/c-myc signal circuit e-cadherin controls beta-catenin gemcitabine-induced epithelial-mesenchymal transition trkb-induced epithelial-mesenchymal transition downregulating estrogen receptor-alpha high-invasive erα-negative cells triple-negative breast cancer open-access article distributed erα-negative mda-mb-231 cells erα-negative mda-mb-468 cells data availability statement porta-de-la-riva erα-negative breast cancer erα-negative breast tumors erα-positive breast cancer nf-kappab transcriptional activity emt-induced transcription factors inhibit e-cadherin transcription carb-box-binding factor long-term prognostic risk mcf-7/adr cell lines anti-e-cadherin antibody e-cadherin citation drug resistance view e-cadherin gene transcription erα-negative tumor subtypes dox-resistant mcf-7/adr cells chemotherapy-induced drug resistance mouse tumor model showing mesenchymal-epithelial transition tris-buffered saline solution estrogen receptor α erα-negative mda-mb-231 erα-positive mcf-7/adr erα-positive mcf-7 cells emt-related transcription factors research search frontiers ethics statement erα-mediated emt pathway slug regulates e-cadherin zhe-sheng chen department twist-snail axis critical bogu biology company mda-mb-468 cells transfected positive breast cancer erα overexpressing cells repressing e-cadherin expression esr1 plasmids-transfected cells anthracyclines-based neoadjuvant chemotherapy breast cancer cells

Schema {🗺️}

ScholarlyArticle:
      context:https://schema.org
      headline:Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-Cadherin
      author:
            type:Person
            name:Xiaoqing Wan
            affiliation:
               Laboratory of Molecular Oncology, Weifang Medical University, China
               Department of Pathophysiology, Weifang Medical University, China
            type:Person
            name:Jiaxin Hou
            affiliation:
               School of Physical Education & Sports Science, Qufu Normal University, China
            type:Person
            name:Shurong Liu
            affiliation:
               Laboratory of Molecular Oncology, Weifang Medical University, China
            type:Person
            name:Yanli Zhang
            affiliation:
               Department of Pathophysiology, Weifang Medical University, China
            type:Person
            name:Wenqing Li
            affiliation:
               Laboratory of Molecular Oncology, Weifang Medical University, China
            type:Person
            name:Yanru Zhang
            affiliation:
               Laboratory of Molecular Oncology, Weifang Medical University, China
            type:Person
            name:Yi Ding
            affiliation:
               Department of Pathophysiology, Weifang Medical University, China
               Key Laboratory of Applied Pharmacology, Weifang Medical University, China
      datePublished:2021-02-04
      dateModified:2025-07-01
      publisher:
         type:Organization
         name:Frontiers
      isPartOf:
         type:PublicationIssue
         datePublished:2021
         isPartOf:
            type:PublicationVolume
            volumeNumber:9
            isPartOf:
               type:Periodical
               name:Frontiers in Cell and Developmental Biology
      citation:
         https://doi.org/10.3389/fcell.2021.583572
      inLanguage:en
Person:
      name:Xiaoqing Wan
      affiliation:
         Laboratory of Molecular Oncology, Weifang Medical University, China
         Department of Pathophysiology, Weifang Medical University, China
      name:Jiaxin Hou
      affiliation:
         School of Physical Education & Sports Science, Qufu Normal University, China
      name:Shurong Liu
      affiliation:
         Laboratory of Molecular Oncology, Weifang Medical University, China
      name:Yanli Zhang
      affiliation:
         Department of Pathophysiology, Weifang Medical University, China
      name:Wenqing Li
      affiliation:
         Laboratory of Molecular Oncology, Weifang Medical University, China
      name:Yanru Zhang
      affiliation:
         Laboratory of Molecular Oncology, Weifang Medical University, China
      name:Yi Ding
      affiliation:
         Department of Pathophysiology, Weifang Medical University, China
         Key Laboratory of Applied Pharmacology, Weifang Medical University, China
Organization:
      name:Frontiers
PublicationIssue:
      datePublished:2021
      isPartOf:
         type:PublicationVolume
         volumeNumber:9
         isPartOf:
            type:Periodical
            name:Frontiers in Cell and Developmental Biology
PublicationVolume:
      volumeNumber:9
      isPartOf:
         type:Periodical
         name:Frontiers in Cell and Developmental Biology
Periodical:
      name:Frontiers in Cell and Developmental Biology

Social Networks {👍}(7)

External Links {🔗}(233)

Libraries {📚}

Vue.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Cloudflare
Crossref

4.89s.